A clinical study on prostate cancer diagnosis with cDNA macroarray

Chinese Journal of Cancer Research

Volumn 17, Issue 1, 2005, Pages 66-70

  Zhong, Wei De ^a   Liu, Liang Shi ^b   Liu, Wen Hua ^b   Jiang, Fu Neng ^b   Zeng, Guang Qiao ^a   Dai, Qi Shan ^a   He, Hui Chan ^a   Bi, Xue Cheng ^a   Peng, Zhi Qiang ^a   Xie, Ke Ji ^a   Wei, Hong Ai ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

cDNA macroarray; Neoplasm; Prostate

Indexed keywords

POLYADENYLIC ACID; RNA;

ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENE EXPRESSION; HUMAN; PROSTATE CANCER; RNA ISOLATION; UPREGULATION;

EID: 20244369282     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-005-0014-5     Document Type: Article

References (14)

1. Marshall A, Hodgson J. DNA chips: an array of possibilities [J]. Nat Biotechnol 1998; 16:27-31.
2. Calvo A, Xiao N, Kang J, et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors [J]. Cancer Res 2002; 62:5325-35.
3. Brooks JD. Microarray analysis in prostate cancer research [J]. Curr Opin Urol 2002; 12:395-9.
4. Burger MJ, Tebay MA, Keith PA, et al. Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer [J]. Int J Cancer 2002; 100:228-37.
5. Ho SM, Lau KM. DNA microarrays in prostate cancer [J]. Curr Urol Rep 2002; 3:53-60.
6. Luo JH, Yu YP. Genetic factors underlying prostate cancer [J]. Expert Rev Mol Med 2003; 5:1-26.
7. Gurova KV, Roklin OW, Krivokrysenko VI, et al. Expression of prostate specific antigen (PSA) is negatively regulated by p53 [J]. Oncogene 2002; 21:153-7.
8. Rubin MA, Dunn R, Strawderman M, et al. Tissue microarray sampling strategy for prostate cancer biomarker analysis [J]. Am J Surg Pathol 2002; 26:312-9.
9. Porkka KP, Visakorpi T. Molecular mechanisms of prostate cancer [J]. Eur Urol 2004; 45:683-91.
10. Wong YC, Wang XH, Ling MT. Prostate development and carcinogenesis [J]. Int Rev Cytol 2003; 227:65-130.
11. Gonzalgo ML, Isaacs WB. Molecular pathways to prostate cancer [J]. J Urol 2003; 170(6 Pt 1): 2444-52.
12. Edwards J, Krishna NS, Witton CJ, Bartlett JM. Gene amplifications associated with the development of hormone-resistant prostate cancer [J]. Clin Cancer Res 2003; 9:5271-81.
13. Recker F, Kwiatkowski MK, Piironen T, et al. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen [J]. Urology 2000; 55:481-5.
14. Chaib H, Cockrell EK, Rubin MA, et al. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis [J]. Neoplasia 2001; 3:43-52.